Skin
Eczema (Atopic Dermatitis)
Eczema (Atopic Dermatitis) is a skin condition involving clinical skin signs and pruritus, or itching. It refers to the overall condition rather than to a single measurement, such as class E antibody levels, which may be elevated in cases of atopic dermatitis.
Eczema (Atopic Dermatitis) is a skin condition. Find focused information about this condition in one place.
This list shows research findings, not treatments. Nothing here replaces medical care. If you have this condition, talk to a doctor.
What may help
What studies found for each option, best evidence first.
1 option:1 some evidence
Cupping TherapypracticeSome evidence it helpsSize of effect: Not known
Some human studies found a benefit. More research could change this.
All 2 studies with a clear result found a benefit.
A 2024 meta-analysis of 19 RCTs reported efficacy comparable to high-potency steroids, with improved outcomes when cupping was combined with medication or moxibustion. A separate 2020 protocol concerned neurodermatitis but presented no results.
Open the Cupping Therapy page
The expert view shows every study, dose protocol and source.
What may help
Interventions recorded as helping with this condition1 listedMost likely to help, from the evidence we have
- →PracticesCupping TherapyCertaintyMediumSourceClinical
A 2024 meta-analysis of 19 RCTs reported efficacy comparable to high-potency steroids, with improved outcomes when cupping was combined with medication or moxibustion. A separate 2020 protocol concerned neurodermatitis but presented no results.
Who was studied
- People with a condition
- Eczema
Open Cupping TherapyStudy result
Meta-analysis of 19 RCTs showing comparable efficacy to high-potency steroids and improved outcomes when combined with medication or moxibustion.
What to avoid
Interventions recorded as making it worseNothing in this library is currently recorded as making Eczema (Atopic Dermatitis) worse. Coverage is partial, and absence here is not evidence of safety.
How to read the evidence
Evidence tier — overall strength of the evidence for the whole compound
- StrongWell established — backed by strong, consistent human research.
- ModerateSome genuine support, but mostly from small or lower-quality studies. Promising, not proven.
- PreliminaryEarly-stage evidence — a promising hypothesis, not an established effect yet.
- LimitedVery limited evidence — treat this as a hypothesis, not proof.
- InsufficientNot enough good evidence to draw conclusions yet.
Certainty — how sure we can be that the effect is real
- Very highVery sure — strong, consistent evidence
- HighFairly sure — consistent evidence from good studies
- MediumModerately sure — new studies could change this
- LowNot sure — little or mixed evidence
- Very lowVery unsure — almost no usable evidence
Source — where the data comes from
- Meta-analysisPooled analysis of many trials — the strongest evidence
- RCTRandomized controlled trial — a strong human study design
- ClinicalA human clinical study
- Reference knowledgeFrom general health-science or pharmacology references, not a study of this exact claim
- Animal researchStudied in animals, not humans
- Community reportsAggregated user reports — anecdotal signal, not evidence
- TheoreticalMechanism-based reasoning, not yet tested
Study grade — quality of each underlying study (A best, D weakest)
- AHigh-quality — strong, consistent human trials
- BGood — solid evidence with some limitations
- CModerate — limited, small, or mixed-quality studies
- DWeak — preliminary, indirect, or animal-only
Confidence — how strongly the sources back a finding
A 0–100 score from study quality and agreement
Most supplement evidence is graded C–D. Read it as preliminary signal, not proof.
Full write-up
What is it
Eczema (Atopic Dermatitis) is a skin condition involving clinical skin signs and pruritus, or itching. It refers to the overall condition rather than to a single measurement, such as class E antibody levels, which may be elevated in cases of atopic dermatitis. Information about options such as CBD (Cannabidiol), Evening Primrose Oil, Astragalus, and Melatonin concerns their studied relationship with this condition and does not redefine what eczema is.
Evidence-backed options
The options studied for Eczema (Atopic Dermatitis) span oral supplements, topical products, and a behavioral approach. Reported findings cover several types of outcomes, including skin symptoms, itch, skin barrier function, quality of life, scratching, and immune-related markers. These outcomes are not interchangeable, so an improvement in one does not necessarily indicate broader disease control.
The evidence remains limited overall: most options are associated with low likelihood of benefit, while Yoga is associated with very low likelihood of benefit. The evidence comes from reviews, clinical findings, and an RCT, but the available findings do not establish a consistent treatment duration or how quickly effects may appear. The clearest formulation detail is a 1% CBD-infused gel; the other reports do not provide a consistent basis for comparing doses, durations, or onset.
Some findings concern laboratory markers or results from a specific preparation rather than confirmed, generalizable control of Eczema (Atopic Dermatitis). For example, the evidence involving Resveratrol relates to resveratrol-enriched rice, while Vitamin B3 (Niacin) relates to niacinamide-containing body emollients. Most studies do not specify the health status of the participants, which limits how confidently the findings can be applied to particular people. Melatonin is described as a possible add-on for selected patients, but routine use for disease control cannot be recommended on current evidence. Anyone considering an option for this medical condition should discuss its relevance with a clinician.